Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01978392 · ClinicalTrials.gov registry record · NA

MANAGE AT WORK: Addressing the Challenge of Chronic Physical Health Conditions in the Workplace

A NA study of Chronic Physical Health Conditions, sponsored by Liberty Mutual Research Institute for Safety.

Completed
Registry status
NA
Development phase
122
Enrollment target
4
Study locations

NCT01978392: Completed NA study of Chronic Physical Health Conditions, sponsored by Liberty Mutual Research Institute for Safety.

NCT01978392 is a NA study of Chronic Physical Health Conditions that has completed, run by Liberty Mutual Research Institute for Safety. The registered enrollment target is 122 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01978392, a NA study of Chronic Physical Health Conditions, has completed, sponsored by Liberty Mutual Research Institute for Safety.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target
4
Study locations

Study Summary

The specific aim of the study is to evaluate the health benefits of a series of group workshops designed for workers with chronic physical health conditions. The facilitated workshops apply principles of pain and illness self-management to help workers deal with health-related challenges while at work. The workshops address issues of pain management, physical job demands, pacing of work, communication, problem solving, and coping. Half of the participants in the study will be randomly assigned to attend workshop sessions (10 hours total), and all study participants will be followed for one year. The primary hypothesis is that workers who participate in these workshops will show improvements in work engagement and reductions in work limitation in the subsequent 12 months.

Primary Outcome

The Work Limitations Questionnaire (WLQ)(Lerner et al., 2003) is a 25-item self-report questionnaire that assesses the degree to which working individuals are experiencing limitations on-the-job due to their health problems and health-related productivity loss. The WLQ asks respondents to rate their level of difficulty or ability to perform specific job demands. Items are grouped into 4 scales: (1) time management; (2) physical demands; (3) mental-interpersonal demands; and (4) output demands.

Interventions

  • BEHAVIORAL Self-management group workshops

Study Locations (4)

New Hampshire

  • Dartmouth-Hitchcock Medical Center - Hanover
  • Employer #4 (Confidential) - Hanover

Massachusetts

  • Employer #3 (confidential) - Worcester

Rhode Island

  • Employer #2 (confidential) - Providence

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2013-11
Est. Completion 2017-05-31
Phase NA

What the finished NCT01978392 record still lists

NCT01978392 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Chronic Physical Health Conditions appearing as the primary indexed condition, and to 1 intervention - of which Self-management group workshops is the first listed.

NCT01978392 reports a single indexed study location in New Hampshire, Massachusetts, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01978392 about?

NCT01978392 is a clinical study titled "MANAGE AT WORK: Addressing the Challenge of Chronic Physical Health Conditions in the Workplace". The specific aim of the study is to evaluate the health benefits of a series of group workshops designed for workers with chronic physical health conditions. The facilitated workshops apply principles of pain and illness self-management to help workers deal with health-related challenges while at wo...

What is the current status of trial NCT01978392?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2013-11. Estimated completion is 2017-05-31.

What conditions does trial NCT01978392 study?

This clinical trial studies the following conditions: Chronic Physical Health Conditions.

What interventions are being tested in trial NCT01978392?

The interventions under investigation include: Self-management group workshops (BEHAVIORAL).

Who is sponsoring clinical trial NCT01978392?

This trial is sponsored by Liberty Mutual Research Institute for Safety, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01978392 being conducted?

This trial has 4 study locations across Massachusetts, New Hampshire, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT01978392's enrollment target sits among peer trials

122 762nd of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03363373 · 122 participants · Phase 2

    Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

  • NCT03463954 · 122 participants · NA

    Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

  • NCT04503265 · 122 participants · Phase 1

    A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

  • NCT04700527 · 122 participants · Phase 1

    The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01978392, the US trial registry maintained by the National Library of Medicine. NCT01978392 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.